Comparison between Clinitech Laboratory IPO and Manglam Infra IPO.
IPO Details
Clinitech Laboratory IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Manglam Infra IPO is a SME Bookbuilding proposed to list at NSE SME.
The total issue size of Clinitech Laboratory IPO is up to ₹5.48 Cr whereas the issue size of the Manglam Infra IPO is up to ₹24.70 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of Manglam Infra IPO is ₹56.00 per share.
Clinitech Laboratory IPO opens on Jul 25, 2024, while Manglam Infra IPO opens on Jul 24, 2024. The closing date of Clinitech Laboratory IPO and Manglam Infra IPO is Jul 29, 2024, and Jul 26, 2024, respectively.
In the Clinitech Laboratory IPO Retail Individual Investors (RII) are offered 2,85,600 shares while in Manglam Infra IPO retail investors are offered 2,85,600 shares. Qualified Institutional Buyers (QIB) are offered in Clinitech Laboratory IPO and 8,82,000 shares in Manglam Infra IPO.